學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
The Teladoc and Livongo Merger
內容大綱
Teladoc and Livongo had ridden the tailwinds of the COVID-19 pandemic-and a merger between the two would offer a "one-stop-shop" for technology-driven care for patients with acute, chronic, and specialty care needs. The case study describes the regulatory history of telemedicine in the United States, and the licensing barriers that had inhibited virtual doctors' visits-until the 2020 COVID-19 pandemic forced urgent changes to the ways doctors and patients interacted. Would the Teladoc business model-and the proposed merger with Livongo-help establish the company firmly in the increasingly competitive telemedicine field? Analysts projected the telehealth space would grow at a compounded annual growth rate of more than 20 percent over the coming years. Livongo, with 147 million members, offered software and personalized health coaching to address diabetes, hypertension, behavioral health, and weight management. Did this acquisition make sense for Teladoc?